Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome

Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome

Objective: to evaluate the efficacy of melatonin and clonazepam versus placebo in patients with burning mouth syndrome (BMS). Methods: a prospective double-blind study was carried out in patients with BMS and randomized to three groups: melatonin (1 mg once a day), clonazepam (0.5 mg/twice a day), o...

Full description

Bibliographic Details
Main Authors: Candela Castillo-Felipe, Asta Tvarijonaviciute, Marina López-Arjona, Luis Pardo-Marin, Eduardo Pons-Fuster, Pia López-Jornet
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
burning mouth syndrome
pain
xerostomia
sleep
melatonin
clonazepam
Online Access:https://www.mdpi.com/2077-0383/11/9/2516

Internet

https://www.mdpi.com/2077-0383/11/9/2516

Similar Items